Dr. Dale E. Mohar, MD

Dr. Mohar practices at Allergy Partners of Kerrville in Kerrville, Texas.

Dr. Mohar's NPI, 1194721696, was assigned on June 21, 2005. Dr. Mohar graduated from Joe R. & Teresa Lozano Long School of Medicine in 1990. Dr. Mohar holds Texas license J0136.

Dr. Mohar's primary practice is Allergy Partners of Kerrville, at 708 Hill Country Dr., Ste 400 Suite 400, Kerrville, TX 78028. The practice phone is (830) 896-1433.

Dr. Mohar's primary practice is Allergy Partners of Kerrville in Kerrville, Texas. Dr. Mohar is also affiliated with Peterson Regional Medical Center. The medical group on file is Allergy Partners of Corpus Christi. Dmand AI also links Dr. Mohar to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mohar practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Mohar's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Mohar is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Mohar is licensed in Texas.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. Mohar treats.

CMS data shows 21,543 Medicare services from Dr. Mohar across 16 procedure codes in 2024, for 636 Medicare patients. Medicare paid $201,581 for them. Every service was in an office.

CMS counts 636 Medicare patients who saw Dr. Mohar in 2024. The largest group is 65 to 74, with 318 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mohar's median patient age at 66, with 63% women.

In 2024, Dr. Mohar wrote 2,830 Medicare Part D claims for 581 patients. 81% of them were for generic drugs. CMS names the drug for 2,690 of them, across 30 drugs with 11 or more claims each, at $351,874 in total drug cost. In 2023, CMS named 2,662 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Mohar for performance year 2024, reported as part of a group. Dr. Mohar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Mohar, published from 2017 to 2019. 2019 was the busiest year, with 2. The most frequent topics are Anti-Allergic Agents, Rhinitis, Allergic, Seasonal and Double-Blind Method. Dr. Mohar has published most often in Allergy Asthma Proc. Dr. Mohar's most frequent co-authors are Frank C. Hampel, MD, Niran Jan Amar, MD and Charles P. Andrews, MD.

Dmand AI links Dr. Mohar to 2 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Asthma and Respiratory Hypersensitivity. GlaxoSmithKline sponsors the most, 2.

CMS Open Payments shows 251 general payments to Dr. Mohar from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. Eli Lilly and Company paid the most, $4,950. It also lists 33 research payments totaling $880,027 from 2016 to 2018.

Dmand AI lists 2 awards for Dr. Mohar, most recently Super Doc in 2013.

Dr. Mohar graduated from Joe R. & Teresa Lozano Long School of Medicine in 1990. Dr. Mohar is a member of AAAAI.

Dr. Mohar is in network with 22 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.